Electrical cardioversion of atrial fibrillation: different methods for a safe and effective technique

References

• Levy S. Epidemiology and natural history of atrial fibrillation. In: Non-pharmacological Treatment of Atrial Fibrillation. Santini M (Ed.), Arianna editrice Casalecchio, BO, Italy (2002).
   Google Scholar
• Bialy D, Lehmann MH, Shumaker DN, Steinman RT, Meissner MD. Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J. Am. Coll. Cardiol. 19, 41A (1992) (Abstract).
   Google Scholar
• Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB. Impact of atrial fibrillation on mortality, stroke and medical costs. Arch. Intern. Med. 158, 229–234 (1998).
   PubMed Web of Science ®Google Scholar
• Falk RH. Atrial fibrillation. N. Engl. J. Med. 344(14), 1067–1078 (2001).
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden L, Asinger RV et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur. Heart J. 22, 1852–1923 (2001).
   PubMed Web of Science ®Google Scholar
• Hagens VE, Van Gelder IC, Crijns HJ et al. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation. Card. Electrophysiol. Rev. 7(2), 118–121 (2003).
   Google Scholar
• The Planning and SteeringCommittees of the AFFIRM study for the NHLBI AFFIRM Investigators. Atrial fibrillation follow-up investigation of rhythm management – the AFFIRM study design. Am. J. Cardiol. 79, 1198–1202 (1997).
   Google Scholar
• Hohnloser SF, Kuck KH. Atrial fibrillation. Maintaining stability of sinus rhythm or ventricular rate control? The need for prospective data: the PIAF trial. Pacing Clin. Electrophysiol. 20, 1989–1992 (1997).
   Google Scholar
• Carlsson J, Boos C. Confounding factors in rate versus rhythm control trials in patients with atrial fibrillation: lessons from the strategies of treatment of atrial fibrillation (STAF) pilot study. Card. Electrophysiol. Rev.7(2), 122–126 (2003).
   Google Scholar
• Tse HF, Lau CP. Advances in internal and external cardioversion. In: Advances in Treatment of Atrial Tachyarrhythmias: Pacing, Cardioversion, and Defibrillation. Israel CW, Barold SS (Eds), Futura Publishing Co., Inc., NY, USA (2002).
   Google Scholar
• Van Gelder IC, Crijns HJ, Van Gilst WH et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm after direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am. J. Cardiol. 68, 41–46 (1991).
   PubMed Web of Science ®Google Scholar
• Alt E, Ammer R, Lehmann G et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am. Heart J. 134, 419–425 (1997).
   PubMed Web of Science ®Google Scholar
• Kosior D, Szulc M, Piatkowski R, Rabczenko D, Torbicki A, Opolski G. Factors determining long-term maintenance of sinus rhythm after cardioversion of persistent atria fibrillation. Kardiol. Pol. 59(8), 128–141 (2003).
   Google Scholar
• Lown B, Amarasingham R, Neuman J. New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. JAMA 182, 548–555 (1962).
   PubMed Web of Science ®Google Scholar
• Mittal S, Ayati S, Stein KM et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101, 1282–1287 (2000).
   PubMedGoogle Scholar
• Page RL, Kerber RE, Russell JK et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation. J. Am. Coll. Cardiol. 39(12), 1956–1963 (2002).
   Google Scholar
• Kerber RE. Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances. Am. J. Cardiol.78, 22–26 (1996).
   Google Scholar
• Emergency Cardiac CareCommittee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Part III. Adult advanced cardiac life support. JAMA 268, 2199–2241 (1992).
   Google Scholar
• Joglar JA, Hamdan MH, Ramaswamy K et al. Initial energy for elective external cardioversion of persistent atrial fibrillation. Am. J. Cardiol. 86, 348–350 (2000).
   PubMed Web of Science ®Google Scholar
• Saliba W, Juratli N, Chung MK et al. Higher energy synchronized external direct current for refractory atrial fibrillation. J. Am. Coll. Cardiol. 34, 2031–2034 (1999).
   Google Scholar
• Neal S, Ngarmukos T, Lessard D et al. Comparison of the efficacy and safety of two biphasic defibrillator waveforms for the conversion of atrial fibrillation to sinus rhythm. Am. J. Cardiol. 92(7), 810–814 (2003).
   Google Scholar
• Prystowsky EN, Benson DW, Fuster V et al. Management of patients with atrial fibrillation: a statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93, 1262–1277 (1996).
   PubMed Web of Science ®Google Scholar
• Klein AL, Grimm RA, Black AW et al. Cardioversion guided by trans-esophageal echocardiography; the ACUTE Pilot Study: a randomized, controlled trial. Ann. Intern. Med.126, 200–209 (1997).
   Google Scholar
• Ricard P, Imianitoff M, Saoudi N. Cardioversion in atrial fibrillation. Rev. Prat. 52(12), 1313–1316 (2002).
   Google Scholar
• Gentile F, Elhendy A, Khandheria BK et al. Safety of electrical cardioversion in patients with atrial fibrillation. Mayo Clin. Proc. 77(9), 895–896 (2002).
   Google Scholar
• Capucci C, Villani GQ, Aschieri D et al. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation. Eur. Heart J. 21, 66–73 (2000).
   Google Scholar
• Sarubbi B, Ducceschi V, D’Andrea A et al. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion? Can. J. Cardiol. 14, 1267–1273 (1988).
   Google Scholar
• Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. J. Am. Coll. Cardiol.28, 700–706 (1996).
   PubMedGoogle Scholar
• Van Gelder IC, Crijns HJ, Van Gilst WH et al. Effects of flecainide on the atrial defibrillation threshold. Am. J. Cardiol.63, 112–116 (1989).
   Google Scholar
• Boriani G, Biffi M, Capucci A et al. Favourable effects of flecainide in transvenous internal cardioversion of atrial defibrillation. J. Am. Coll. Cardiol. 33, 333–341 (1999).
   Google Scholar
• Timmermans C, Rodriguez LM, Smeets JL et al. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J. Cardiovasc. Electrophysiol.9, 122–128 (1998).
   Google Scholar
• Lau CP, Lok NS. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold. Pacing Clin. Electrophysiol. 20, 1–11 (1997).
   Google Scholar
• Lai LP, Lin JL, Lien WP et al. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of electrophysiological effects by biatrial electrodes. J. Am. Coll. Cardiol. 35, 1434–1441 (2000).
   Google Scholar
• Tse HF, Lau CP, Ayers GM et al. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by transvenous sotalol. Heart 82, 319–324 (1999).
   PubMed Web of Science ®Google Scholar
• Oral H, Souza JJ, Michaud GF et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pre-treatment. N. Engl. J. Med. 340, 1849–1854 (1999).
   PubMed Web of Science ®Google Scholar
• Levy S, Lauribe P, Dolla E et al. A randomised comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 86, 1415–1420 (1992).
   Google Scholar
• Alt E, Schmitt C, Ammer R et al. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. Pacing Clin. Electrophysiol. 17, 1067–1078 (1994).
   Google Scholar
• Levy S, Richard P, Gueunoun M et al. Low-energy cardioversion of spontaneous atrial fibrillation: immediate and long-term results. Circulation 96, 253–259 (1997).
   Google Scholar
• Schmitt C, Alt E, Plewan A et al. Low energy intracardiac cardioversion after failed conventional external cardioversion of atrial fibrillation. J. Am. Coll. Cardiol. 28, 994–999 (1996).
   PubMed Web of Science ®Google Scholar
• Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch. Intern. Med. 155, 469–473 (1995).
   PubMed Web of Science ®Google Scholar
• Boriani G, Biffi M, Camanini C et al. Tranvenous internal cardioversion for atrial fibrillation: a randomized comparison between catheters with different coil length. Am. Heart J. 144(5), 851–857 (2002).
   Google Scholar
• Cooper RAS, Johnson EE, Wharton JM et al. Internal atrial defibrillation in humans: improved efficacy of biphasic waveforms and the importance of phase duration. Circulation 95, 1487–1496 (1997).
   Google Scholar
• Murgatroyd FD, Johnson EE, Cooper RA et al. Safety of low-energy transvenous atrial defibrillation: world experience. Circulation 90, 14 (1994).
   Google Scholar
• Tse HF, Lau CP, Sra JS et al. Atrial fibrillation detection and R wave synchronization by Metrix implantable atrial defibrillator: implication for long-term efficacy and safety. Circulation 99, 1446–1451 (1999).
   Google Scholar
• Tse HF, Lau CP. Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function. Am. J. Cardiol. 84, 1090–1092 (1999).
   Google Scholar
• Santini M, Pandozi C, Altamura G et al. Single shock endocavitary low energy intracardiac cardioversion of chronic atrial fibrillation. J. Interv. Card. Electrophysiol. 3(1), 53–54 (1999).
   Google Scholar
• Santini M, Pandozi C, Colivicchi F et al. Transoesophageal low-energy cardioversion of atrial fibrillation. Results with the oesophageal-right atrial lead configuration. Eur. Heart J.21, 848–855 (2000).
   PubMed Web of Science ®Google Scholar
• Pandozi C, Scianaro MC, Magris B et al. Transesophageal low-energy cardioversion of atrial fibrillation without fluoroscopy outside the electrophysiology laboratory. Ital. Heart J. 4(5), 335–340, (2003).
   PubMedGoogle Scholar
• Elhendy A, Gentile F, Khandheria BK et al. Predictors of unsuccessful electrical cardioversion in atrial fibrillation. Am. J. Cardiol. 89, 83–86 (2002).
   PubMed Web of Science ®Google Scholar
• Kerber RE, Grayzel J, Hoyt R, Marcus M, Kennedy J. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 63, 676–682 (1981).
   Google Scholar
• Li HG, Jones DL, Yee R, Klein GJ. Defibrillation shocks increase myocardial pacing threshold: an intracellular microelectrode study. Am. J. Physiol. 260(6 Pt. 2), H1973–H1979 (1991).
   Google Scholar
• Dietl J, Grumbach H, Zrenner B, Sauer E. Selective increase of ventricular pacing threshold with complete exit block following DC cardioversion in a patient with a dual chamber pacemaker. Z. Kardiol.91, 74–80 (2002).
   Google Scholar
• Cai YC, Fan SL, Feng DX et al. Transesophageal low-energy cardioversion in an animal model of life-threatening tachyarrhythmias. Circulation 80(5), 1354–1359 (1989).
   Google Scholar
• McNally EM, Meyer EC, Langendorf R. Elective countershock in unanesthetized patients with use of an esophageal electrode. Circulation 33, 124–127 (1966).
   PubMed Web of Science ®Google Scholar
• McKeown PP, Croal S, Allen JD, Anderson J, Adgey AAJ. Transesophageal cardioversion. Am. Heart. J. 125, 396–404 (1993).
   Google Scholar
• Santini L, Magris B, Ricci RP, Pignalberi C, Russo M, Santini M. Oesophageal cardioversion: an effective and safe technique to restore sinus rhythm. Europace Supplements 4, B131, P-278 (2003).
   Google Scholar
• Yamanouchi Y, Kumagai K, Tashiro N, Hiroki T, Arakawa K. Transesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dog. Am. Heart J. 123, 417–420 (1992).
   PubMed Web of Science ®Google Scholar
• Cochrane D, McEneaney D, Adgey J, Anderson J. Transesophageal and transchest cardioversion – a randomized trial. Pacing Clin. Electrophysiol.15, 566(A) (1992).
   Google Scholar
• Marangoni E, Lissoni F, Bucci L et al. Rationale for oesophageal cardioversion of atrial fibrillation. In: Progress in Clinical Pacing. Santini M (Ed), Futura Media Service, NY, USA (1999).
   Google Scholar
• Zumbo F, Antonelli A, Franciosa P, Mangiameli D, Bruno N, Montenero AS. Transoesophageal cardioversion for atrial fibrillation: preliminary results of bi-directional approach. Proceedings of the VII Asian-Pacific Symposium on Cardiac Pacing and Electrophysiology (2001).
   Google Scholar
• Zardo F, Brieda M, Hrovatin E et al. Transesophageal electrical cardioversion of persistent atrial fibrillation: a new approach for an old technology. Ital. Heart J. 3(6), 354–359 (2002).
   PubMedGoogle Scholar
• Bartoletti A, Campana A, Chiodi L et al. Cardioversione elettrica con shock esofageo bifasico in pazienti con fibrillazione striale persistente refrattaria alla cardioversione elettrica transtoracica. G. Ital. Aritmol. Cardiostim. 3, 136–142 (2002).
   Google Scholar